TV commercial highlights cortisol issues in type 2 diabetes

January 17, 2025

Corcept Therapeutics moves forward with a groundbreaking advertising campaign to increase awareness of Cushing’s by focusing on the results of recent research conducted by the company that shows that almost 25% of people with difficult-to-treat Type-2 diabetes may, in fact, have Cushing’s Syndrome, which could, also be the underlying cause of the diabetes.

The complex diagnosis of Cushing’s syndrome

May 8, 2020

In this engaging podcast about the diagnosis of Cushing’s syndrome, Pituitary Worlds News co-founder and Medical Director, California Center for Pituitary Disorders at UCSF Professor of Clinical Medicine and Clinical Neurological Surgery, Dr. Lewis Blevins

Positive news for new Cushing’s drug

September 23, 2019

In a press release, Strongbridge Biopharma announced comprehensive positive results of their Phase 3 SONICS study of RECORLEVTM (levoketoconazole) for the potential treatment of endogenous Cushing’s syndrome. The results were published online in The Lancet